Clinical Trial Update: SWiss Multicenter Intracoronary Stem Cells Study in Acute Myocardial Infarction (SWISS-AMI) [Phase 2]

View source ↗

Summary

Phase 2 SWISS-AMI trial evaluating intracoronary stem cell therapy for acute myocardial infarction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Intracoronary stem cell therapy

Snippet

Sponsor: University of Zurich | Conditions: Acute Myocardial Infarction | Phase 2 | Status: COMPLETED